Related Experiment Video
Updated: Jun 26, 2026
08:41
Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
Pharmacological interactions of vasoconstrictors
Gerardo Gómez-Moreno1, Javier Guardia, Antonio Cutando
1Pharmacological Interactions in Odontological Patients with Systemic Pathology, Clinical Odontology for Special Patients, Department of Odontology, University of Granada, Spain. ggomez@ugr.es
Medicina Oral, Patologia Oral Y Cirugia Bucal
|December 31, 2008
Summary
Dentists must understand drug interactions between local anesthetics with vasoconstrictors and other medications. This awareness is crucial for preventing adverse reactions in patients with increased medication use.
Area of Science:
- Pharmacology
- Odontology
- Drug Interactions
Background:
- Growing elderly population and increased chronic conditions lead to higher medication consumption.
- Odontological procedures often involve local anesthetics containing vasoconstrictors like adrenaline (epinephrine).
- Vasoconstrictors enhance anesthesia efficacy but pose risks of drug interactions.
Purpose of the Study:
- To highlight the importance of odontologists understanding pharmacological interactions.
- To inform about potential adverse reactions from drug combinations in dental patients.
- To emphasize the need for comprehensive patient medication history.
Main Methods:
- Review of pharmacological interactions relevant to odontology.
- Focus on vasoconstrictors in local anesthetics and their interactions.
- Discussion of anti-inflammatory and anti-microbial analgesics.
Main Results:
- Adrenaline (epinephrine) in local anesthetics improves anesthesia but can interact with other drugs.
- Interactions may occur between injected vasoconstrictors and systemically administered adrenergic medications.
- Increased risk of adverse reactions necessitates careful patient assessment.
Conclusions:
- Odontologists must be vigilant about potential drug interactions.
- Thorough patient medical history, including all medications, is essential.
- Awareness of drug interactions is critical for patient safety in odontology.
Related Concept Videos
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:30Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
01:13Local Anesthetics: Pharmacokinetics
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...